Change in Age Limit for Pharmacist-Administered Influenza Vaccines
For more information please click here.
Kidney Health Care Adds New Drugs to Formulary
For more information please click here.
COVID-19 Vaccine Booster Update
For more information please click here.
Semi-annual Medicaid Preferred Drug List Update Coming January 27, 2022
For more information please click here.
Draft of Medication Therapy Management Policy Available for Comment
For more information please click here.
Stimate Nasal Spray National Drug Shortage
For more information please click here.
Pharmacy Services Change of Ownership (CHOW) Interim Process
For more information please click here.
Promethazine Clinical Prior Authorization Criteria Updates Scheduled for December 7, 2021
For more information please click here.
Dupixent Clinical Prior Authorization Criteria Update Scheduled for January 4, 2022
For more information please click here.
Clinical Prior Authorization Assistance Chart Now Available
For more information please click here.
November 2021 Drug Utilization Review Board Meeting Summary
For more information please click here.
July 2021 Preferred Drug List Revised December 3, 2021
For more information please click here.
Removal of Specialist Requirement from Clinical Prior Authorization Criteria Scheduled for January 3, 2022
For more information please click here.
Agenda for November Drug Utilization Review Board Meeting Now Available
For more information please click here.
Order and Administration of Selected COVID-19 Monoclonal Antibody Therapeutics Reimbursable Through Medicaid Medical Claims System
For more information please click here.
COVID-19 Vaccine Coverage Update: Comirnaty and Pfizer Age Change
For more information please click here.
Removal of Specialist Requirement from Clinical Prior Authorization Criteria Scheduled for January 3, 2021
For more information please click here.
Coverage of COVID-19 Booster Doses of Moderna and Johnson & Johnson Vaccines
For more information please click here.
RightCare Provider Newsletter
For the latest newsletter click here.
October 2021 NDC-to-HCPCS Crosswalk Now Available
For more information please click here.
Updates to Medicaid Preferred Drug List Scheduled for November 15, 2021
For more information please click here.
Pharmacy Submittal of COVID-19 Vaccine Additional, Booster Doses
For more information please click here.
Nucala Clinical Prior Authorization Update Scheduled for December 14, 2021
For more information please click here.
Repatha (evolocumab) Prior Authorization Update Scheduled for December 6, 2021
For more information please click here.
Hepatitis C Drug Rebate Program Procurement Information Now Available
For more information please click here.
HHSC Updates Respiratory Syncytial Virus (RSV) Season Schedule
For more information please click here.
HHSC Issues Stromectol (Ivermectin) Guidance
For more information please click here.
Temporary Change in Texas Pharmacy Prior Authorization Call Center Phone Number
For more information please click here.
Alinia Clinical Prior Authorization Criteria Revision Effective November 23, 2021
For more information please click here.
Updating Pharmacy Claim Systems for COVID-19 Vaccine Additional Doses
For more information please click here.
2021-22 RSV Assessment and Synagis Authorization
For more information please click here.
Changes to Hepatitis C Prior Authorization Criteria Begin September 1, 2021
For more information please click here.
Duplicate Therapy Clinical Prior Authorization Criteria Revision Begins October 19, 2021
For more information please click here.
Respiratory Syncytial Virus and Synagis Authorization During Summer and Winter 2021-2022
For more information please click here.
July 2021 Drug Utilization Review Board Meeting Summary
For more information please click here.
Home Health Care Services Required to Use EVV by Jan. 1, 2023
To comply with the 21st Century Cures Act (Section 12006) federal law, HHSC has started identifying programs, services and service delivery options related to home health care services required to use EVV by Jan. 1, 2023 (PDF). HHSC will continue to analyze these services and additional updates may be made.
Please visit the 21st Century Cures Act webpage for the latest information about the EVV home health care services implementation.
To receive related notifications and current EVV updates, sign up for EVV alerts.
Email questions to HHSC EVV Operations.
Atypical Respiratory Syncytial Virus (RSV) Season Advisory
For more information please click here.
April 2021 Preferred Drug List Decisions Now Available
For more information please click here.
July 2021 Preferred Drug List Now Available
For more information please click here.
Changes to Hepatitis C Prior Authorization Criteria Begin September 1, 2021
For more information please click here.
Trikafta Age Expansion in Cystic Fibrosis Agents Clinical Prior Authorization Begins September 1, 2021
For more information please click here.
Nucala Clinical Prior Authorization Criteria Update Begins July 12, 2021
For more information please click here.
Semi-annual Medicaid Preferred Drug List Update Coming July 29, 2021
For more information please click here.
Urgent: Texas Medicaid Guidance in Response to Philips Recall of Respiratory Devices
For more information please click here.
HHSC to Reopen RSV Season in Select Regions on June 21, 2021
For more information please click here.
Do your patients need Nonemergency Medical Transportation (NEMT)?
For more information please click here.
Medicaid Allows Pfizer BioNTech COVID-19 Vaccine for Emergency Use in Adolescents
For more information please click here.
HHSC to Resume Quarterly Specialty Drug List in July 2021
For more information please click here.
COVID-19 Testing in Pharmacy Reimbursable Through Medicaid Medical Claims System
For more information please click here.
Clinical Prior Authorization Assistance Chart Now Available
For more information please click here.
April 2021 Preferred Drug List Recommendations Now Available
For more information please click here.
COVID-19 Vaccine Administration Rate Change Effective April 1, 2021
For more information please click here.
January 2021 Preferred Drug List Decisions Now Available
For more information please click here.
Enzymes Clinical Prior Authorization Criteria Revisions Effective June 30, 2021
For more information please click here.
Frequently Asked Questions about the Medicaid Standing Order for Mosquito Repellent
For more information please click here.
Epidiolex Prior Authorization Revision Scheduled for May 11, 2021
For more information please click here.
Medicaid Adds Johnson & Johnson COVID-19 Vaccine to Formulary
For more information please click here.
Revised Hepatitis C Drug Prior Authorization Form 1342
For more information please click here.
January 2021 Preferred Drug List Revised March 5, 2021
For more information please click here.
Revisions to Cytokine and CAM Antagonists Prior Authorization Criteria Set for May 4, 2021
For more information please click here.
RSV Season Extended for Counties in Southeast Texas and Gulf Coast Areas
For more information please click here.
IVR and Provider Portals for Member Information.
For more information please click here.
Monoclonal Antibody for Asthma Prior Authorization Updates Set for April 6, 2021.
For more information please click here.
Revised Hepatitis C Drug Prior Authorization Forms Now Available.
For more information please click here.
Clinical Prior Authorization Updates for Cystic Fibrosis Agents.
For more information please click here.
Preferred Drug List Criteria Exception for Macrolides Changes March 15.
For more information please click here.
Renewed Texas Standing Order for Mosquito Repellent Benefit Available.
For more information please click here.
Clinical Prior Authorization Assistance Chart Now Available.
For more information please click here.
January 2021 Preferred Drug List Now Available.
For more information please click here.
COVID-19 Vaccine Facts.
For more information please click here.
Desmopressin Clinical Prior Authorization Revision Begins March 15, 2021.
For more information please click here.
COVID-19 Vaccine NDC Update.
For more information please click here.
Dupixent Clinical Prior Authorization Criteria Revision Effective March 15, 2021.
For more information please Dupixent Clinical Prior Authorization Criteria Revision Effective March 15, 2021.
Quality Improvement webinar for ADHD HEDIS Measure (Initiation Phase).
Portia Green, SWHP’s Clinical Quality Improvement Coordinator, will host a presentation on follow-up care for children prescribed medications for attention-deficit hyperactivity disorder. This presentation is part one of a two-part series on the initiation and continuation phases of ADHD treatment.
For more information please click here.